Zymeworks (ZYME) Amortizatization of Intangibles (2021 - 2026)
Zymeworks' (ZYME) quarterly Amortizatization of Intangibles came in at $176000.0 in Q1 2026, down 75.11% year-on-year from $707000.0 in Q1 2025, and down 80.95% quarter-over-quarter from $924000.0 in Q4 2025.
Zymeworks (ZYME) Amortizatization of Intangibles (2021 - 2026) Analysis & Trends
Zymeworks has disclosed Amortizatization of Intangibles across 6 years of filings, most recently posting $176000.0 for Q1 2026.
- Amortizatization of Intangibles for Q1 2026 came in at $176000.0, down 75.11% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.9 million (down 36.59% YoY), and the FY2025 annual result was $3.4 million, down 24.71% from the prior year.
- Amortizatization of Intangibles came in at $176000.0 for Q1 2026 at Zymeworks, down from $924000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $2.9 million in Q1 2022 to a low of $176000.0 in Q1 2026.
- The 5-year median for Amortizatization of Intangibles is $707000.0 (2025), against an average of $913411.8.
- Across the five-year window, Amortizatization of Intangibles surged 231.75% in 2022 and tumbled 77.77% in 2023, its largest moves.
- Zymeworks' Amortizatization of Intangibles stood at $627000.0 in 2022, then increased by 7.34% to $673000.0 in 2023, then surged by 197.47% to $2.0 million in 2024, then tumbled by 53.85% to $924000.0 in 2025, then sank by 80.95% to $176000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $176000.0 (Q1 2026), $924000.0 (Q4 2025), and $1.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Zymeworks | 1.73 Bn | 1.36 Bn | - | 176,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 176,000.00 |
| Mar 31, 2026 | 176,000.00 |
| Dec 31, 2025 | 924,000.00 |
| Dec 31, 2025 | 924,000.00 |
| Sep 30, 2025 | 1.03 Mn |
| Sep 30, 2025 | 1.03 Mn |
| Jun 30, 2025 | 723,000.00 |
| Jun 30, 2025 | 723,000.00 |
| Mar 31, 2025 | 707,000.00 |
| Mar 31, 2025 | 707,000.00 |
| Dec 31, 2024 | 2.00 Mn |
| Dec 31, 2024 | 2.00 Mn |
| Sep 30, 2024 | 980,000.00 |
| Sep 30, 2024 | 980,000.00 |
| Jun 30, 2024 | 812,000.00 |
| Jun 30, 2024 | 812,000.00 |
| Mar 31, 2024 | 702,000.00 |
| Mar 31, 2024 | 702,000.00 |
| Dec 31, 2023 | 673,000.00 |
| Dec 31, 2023 | 673,000.00 |